Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Bacterial disease diagnostics market size to increase by USD 3,766.05 million between 2022 and 2027; Growth driven by high prevalence of infectious diseases - Technavio

NEW YORK, March 22, 2023 /PRNewswire/ -- The bacterial disease diagnostics market size is forecast to grow by USD 3,766.05 million between 2022 and 2027. However, the growth momentum will be decelerating at a CAGR of 6.28% during the forecast period. The growth of the market is driven by factors such as the high prevalence of infectious diseases, the integration of digital health in rapid diagnostics for bacterial disease, and the growing number of merger and acquisition (M&A) activities.

The number of disease outbreaks has increased significantly over the past few years. Factors such as malnutrition, poor sanitation, poor water quality, and the lack of proper healthcare systems have increased the prevalence of infectious diseases. For instance, according to WHO, in 2020, an estimated 10 million people fell ill with tuberculosis (TB) worldwide. Similarly, the incidence of infectious diseases such as TB, malaria, and hepatitis is increasing worldwide. The rise in the incidence of various infectious diseases has increased the demand for bacterial disease diagnostics. All these factors are driving the growth of the market in focus. For more insights on the historic data (2017 to 2021) and forecast market size (2023 to 2027) ? Request a report sample

Regional Analysis

By region, the global bacterial disease diagnostics market is segmented into North America, Europe, Asia, and Rest of World (ROW). North America will account for 49% of market growth during the forecast period. The increase in the prevalence of bacterial diseases such as TB, meningitis, and pneumonia has been crucial in driving the growth of the regional market. The development of new antibacterial drugs and the increase in funding for the development of new therapies are other major factors supporting the growth of the bacterial disease diagnostics market in North America.

Company Profiles

The global bacterial disease diagnostics market is fragmented due to the presence of several global and regional players. Key vendors are developing a comprehensive range of advanced bacterial disease diagnostics to strengthen their position and cater to the demands of end-users. Prominent vendors are trying to build a strong customer base by distributing the products through subsidiaries and other distribution channels worldwide. Besides, the market is witnessing collaborations and tie-ups of vendors with clinics and practitioners. All these factors will intensify the competition in the market during the forecast period.

The bacterial disease diagnostics market report includes information on the key products and recent developments of leading vendors, including:

Competitive Analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share among others. Request a Sample

Market Segmentation

Why Buy?

Grow your profit margin with Technavio ? Buy the Report!

What are the key data covered in this bacterial disease diagnostics market report?

Related Reports:

Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to Technavio Insights

Bacterial Disease Diagnostics Market Scope

Report Coverage


Base year


Historic period


Forecast period


Growth momentum & CAGR

Decelerate at a CAGR of 6.28%

Market growth 2023-2027

USD 3766.05 million

Market structure


YoY growth 2022-2023 (%)


Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 49%

Key countries

US, Canada, Germany, UK, and Japan

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., GENERI BIOTECH s.r.o., Great Basin Scientific, Hologic Inc., Meridian Bioscience Inc., Perkin Elmer Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, T2 Biosystems Inc., and Takara Bio Inc.

Market dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse through Technavio's Health Care Market Reports
Table of contents:

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Product

7 Market Segmentation by End-user

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape

12 Vendor Analysis

13 Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio

These press releases may also interest you

at 11:00
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Beyond Meat, Inc. ("Beyond Meat" or the "Company") and reminds investors of the July 10, 2023 deadline to seek the role of lead plaintiff in a...

at 11:00
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cutera, Inc. ("Cutera" or the "Company") and reminds investors of the July 24, 2023 deadline to seek the role of lead plaintiff in a federal...

at 07:00
An initiative begun by Barrick president and chief executive Mark Bristow almost 13 years ago has come to fruition with the successful reintroduction of 16 white rhinos to the Garamba National Park in the northeast of the DRC, where the species was...

9 jun 2023
The chemical logistics market size is forecast to increase by USD 53.66 billion from 2023 to 2027, at a CAGR of 3.65%, according to the recent market study by Technavio. The growth of the chemical logistics market depends on several factors,...

9 jun 2023
True stories of successful Overseas Filipinos are making the rounds globally, in time for Independence Day in the Philippines. Videos featuring Charmaine "Charm" Espinoza, a Filipina caregiver in the United Kingdom and Dan Johnson "DJ" Noblesa, a...

9 jun 2023
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 10, 2023 to file lead plaintiff applications in a securities class action lawsuit against Beyond...

News published on and distributed by: